Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies
Main Authors: | van Griensven, J, Edwards, T, Baize, S, Ebola-Tx Consortium, Horby, P |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Massachusetts Medical Society
2016
|
Títulos similares
-
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
por: Emma M. Bentley, et al.
Publicado: (2021-08-01) -
Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration
por: Wesley V Cain, et al.
Publicado: (2022-01-01) -
Symptom-Based Ebola Risk Score for Ebola Virus Disease, Conakry, Guinea
por: Brecht Ingelbeen, et al.
Publicado: (2018-06-01) -
Ebola virus antibody decay–stimulation in a high proportion of survivors
por: Adaken, C, et al.
Publicado: (2021) -
Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
por: A. A. Lopatin, et al.
Publicado: (2015-09-01)